Renal cell carcinoma with lung and iliac bone metastasis treated successfully by a multidisciplinary approach utilizing both interferon-alpha and interleukin-2: A case report

Hiromu Tsuboi, Takashi Saika, Kyohei Kurose, Shinya Uehara, Haruki Kaku, Yasutomo Nasu, Hiromi Kumon, Aya Nakamura

Research output: Contribution to journalArticle

Abstract

We report a case in which intensive combined treatments utilizing both interleukin-2 (IL-2) and interferon alfa (IFN-alpha) were effective against renal cell carcinoma with bone and lung metastases. A 48-year-old man with a left iliac bone tumor was diagnosed by bone biopsy as having metastatic renal cell carcinoma. He was admitted to our hospital for treatment. Computed tomographic (CT) findings showed a left renal tumor 4.8 cm in diameter and multiple lung metastases, as well as an iliac bone tumor. To reduce the bone pain, he first underwent 39 Gy radiation therapy. Then he received 600 × 104 IU/day of IFN-alpha intramuscularly each day. Thereafter, he underwent TAE for the bone tumor followed by 70 × 104 JRU/day of IL-2 (div) 5 times a week. After obtaining bone pain reduction and stable disease of the bone lesion, left nephrectomy was performed, and pathological examination revealed renal cell carcinoma (clear cell carcinoma spindle cell carcinoma, G2 > G3, INF-α, pT1bpN0M1, v (-)). Thereafter, administrations of IL-2 and IFN-alpha were continued as an adjuvant therapy. CT scan showed complete response of the lung metastases and partial response of the iliac bone metastases at 4 months. No recurrence or regrowth has been observed on a CT scan for 8 months since the nephrectomy. Combined intensive therapy including IL-2 and IFN-alpha may have an effective impact on cancer control for patients with metastatic renal cell carcinoma.

Original languageEnglish
Pages (from-to)721-727
Number of pages7
JournalNishinihon Journal of Urology
Volume67
Issue number12
Publication statusPublished - Dec 2005

Fingerprint

Renal Cell Carcinoma
Interferon-alpha
Interleukin-2
Neoplasm Metastasis
Bone and Bones
Lung
Neoplasms
Nephrectomy
Carcinoma
Radiation Dosage
Pain
Bone Diseases
Therapeutics
Radiotherapy
Kidney
Biopsy
Recurrence

Keywords

  • Advanced cancer
  • Combined intensive therapy
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Renal cell carcinoma with lung and iliac bone metastasis treated successfully by a multidisciplinary approach utilizing both interferon-alpha and interleukin-2 : A case report. / Tsuboi, Hiromu; Saika, Takashi; Kurose, Kyohei; Uehara, Shinya; Kaku, Haruki; Nasu, Yasutomo; Kumon, Hiromi; Nakamura, Aya.

In: Nishinihon Journal of Urology, Vol. 67, No. 12, 12.2005, p. 721-727.

Research output: Contribution to journalArticle

Tsuboi, Hiromu ; Saika, Takashi ; Kurose, Kyohei ; Uehara, Shinya ; Kaku, Haruki ; Nasu, Yasutomo ; Kumon, Hiromi ; Nakamura, Aya. / Renal cell carcinoma with lung and iliac bone metastasis treated successfully by a multidisciplinary approach utilizing both interferon-alpha and interleukin-2 : A case report. In: Nishinihon Journal of Urology. 2005 ; Vol. 67, No. 12. pp. 721-727.
@article{e57a9835555d4de0a5dafe4fe2140977,
title = "Renal cell carcinoma with lung and iliac bone metastasis treated successfully by a multidisciplinary approach utilizing both interferon-alpha and interleukin-2: A case report",
abstract = "We report a case in which intensive combined treatments utilizing both interleukin-2 (IL-2) and interferon alfa (IFN-alpha) were effective against renal cell carcinoma with bone and lung metastases. A 48-year-old man with a left iliac bone tumor was diagnosed by bone biopsy as having metastatic renal cell carcinoma. He was admitted to our hospital for treatment. Computed tomographic (CT) findings showed a left renal tumor 4.8 cm in diameter and multiple lung metastases, as well as an iliac bone tumor. To reduce the bone pain, he first underwent 39 Gy radiation therapy. Then he received 600 × 104 IU/day of IFN-alpha intramuscularly each day. Thereafter, he underwent TAE for the bone tumor followed by 70 × 104 JRU/day of IL-2 (div) 5 times a week. After obtaining bone pain reduction and stable disease of the bone lesion, left nephrectomy was performed, and pathological examination revealed renal cell carcinoma (clear cell carcinoma spindle cell carcinoma, G2 > G3, INF-α, pT1bpN0M1, v (-)). Thereafter, administrations of IL-2 and IFN-alpha were continued as an adjuvant therapy. CT scan showed complete response of the lung metastases and partial response of the iliac bone metastases at 4 months. No recurrence or regrowth has been observed on a CT scan for 8 months since the nephrectomy. Combined intensive therapy including IL-2 and IFN-alpha may have an effective impact on cancer control for patients with metastatic renal cell carcinoma.",
keywords = "Advanced cancer, Combined intensive therapy, Renal cell carcinoma",
author = "Hiromu Tsuboi and Takashi Saika and Kyohei Kurose and Shinya Uehara and Haruki Kaku and Yasutomo Nasu and Hiromi Kumon and Aya Nakamura",
year = "2005",
month = "12",
language = "English",
volume = "67",
pages = "721--727",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "12",

}

TY - JOUR

T1 - Renal cell carcinoma with lung and iliac bone metastasis treated successfully by a multidisciplinary approach utilizing both interferon-alpha and interleukin-2

T2 - A case report

AU - Tsuboi, Hiromu

AU - Saika, Takashi

AU - Kurose, Kyohei

AU - Uehara, Shinya

AU - Kaku, Haruki

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Nakamura, Aya

PY - 2005/12

Y1 - 2005/12

N2 - We report a case in which intensive combined treatments utilizing both interleukin-2 (IL-2) and interferon alfa (IFN-alpha) were effective against renal cell carcinoma with bone and lung metastases. A 48-year-old man with a left iliac bone tumor was diagnosed by bone biopsy as having metastatic renal cell carcinoma. He was admitted to our hospital for treatment. Computed tomographic (CT) findings showed a left renal tumor 4.8 cm in diameter and multiple lung metastases, as well as an iliac bone tumor. To reduce the bone pain, he first underwent 39 Gy radiation therapy. Then he received 600 × 104 IU/day of IFN-alpha intramuscularly each day. Thereafter, he underwent TAE for the bone tumor followed by 70 × 104 JRU/day of IL-2 (div) 5 times a week. After obtaining bone pain reduction and stable disease of the bone lesion, left nephrectomy was performed, and pathological examination revealed renal cell carcinoma (clear cell carcinoma spindle cell carcinoma, G2 > G3, INF-α, pT1bpN0M1, v (-)). Thereafter, administrations of IL-2 and IFN-alpha were continued as an adjuvant therapy. CT scan showed complete response of the lung metastases and partial response of the iliac bone metastases at 4 months. No recurrence or regrowth has been observed on a CT scan for 8 months since the nephrectomy. Combined intensive therapy including IL-2 and IFN-alpha may have an effective impact on cancer control for patients with metastatic renal cell carcinoma.

AB - We report a case in which intensive combined treatments utilizing both interleukin-2 (IL-2) and interferon alfa (IFN-alpha) were effective against renal cell carcinoma with bone and lung metastases. A 48-year-old man with a left iliac bone tumor was diagnosed by bone biopsy as having metastatic renal cell carcinoma. He was admitted to our hospital for treatment. Computed tomographic (CT) findings showed a left renal tumor 4.8 cm in diameter and multiple lung metastases, as well as an iliac bone tumor. To reduce the bone pain, he first underwent 39 Gy radiation therapy. Then he received 600 × 104 IU/day of IFN-alpha intramuscularly each day. Thereafter, he underwent TAE for the bone tumor followed by 70 × 104 JRU/day of IL-2 (div) 5 times a week. After obtaining bone pain reduction and stable disease of the bone lesion, left nephrectomy was performed, and pathological examination revealed renal cell carcinoma (clear cell carcinoma spindle cell carcinoma, G2 > G3, INF-α, pT1bpN0M1, v (-)). Thereafter, administrations of IL-2 and IFN-alpha were continued as an adjuvant therapy. CT scan showed complete response of the lung metastases and partial response of the iliac bone metastases at 4 months. No recurrence or regrowth has been observed on a CT scan for 8 months since the nephrectomy. Combined intensive therapy including IL-2 and IFN-alpha may have an effective impact on cancer control for patients with metastatic renal cell carcinoma.

KW - Advanced cancer

KW - Combined intensive therapy

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=30344442776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344442776&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:30344442776

VL - 67

SP - 721

EP - 727

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 12

ER -